|
HS Code |
825397 |
| Product Name | Famotidine Disalt |
| Chemical Formula | C8H14N7O2S2Na2 |
| Molecular Weight | 412.36 g/mol |
| Cas Number | 121701-98-4 |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Temperature | 2-8°C |
| Purity | Typically ≥98% |
| Uses | H2 receptor antagonist; antiulcer agent |
| Synonyms | N'-((Aminosulfonyl)iminomethyl)-N-(3-((2-(diaminomethyleneamino)thiazol-4-yl)methylthio)propyl)guanidine disodium salt |
As an accredited Famotidine Disalt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Famotidine Disalt, 25g, packaged in a sealed amber glass bottle with a tamper-evident cap and detailed label. |
| Shipping | Famotidine Disalt is shipped in tightly sealed, corrosion-resistant containers to prevent moisture absorption and ensure product stability. It is packaged according to hazardous materials regulations, with clear labeling and safety documentation. The chemical is transported at ambient temperature, protected from light and incompatible substances, ensuring safe and compliant delivery to the destination. |
| Storage | Famotidine disalt should be stored in a tightly closed container, protected from light and moisture. Keep it at room temperature, ideally between 15–25°C (59–77°F). Avoid exposure to excessive heat and humidity. Store in a well-ventilated area, away from incompatible substances. Follow all relevant safety and handling guidelines as outlined in the material safety data sheet (MSDS). |
|
Purity 99%: Famotidine Disalt with purity 99% is used in pharmaceutical formulation, where it ensures optimal therapeutic efficacy and minimal impurities. Molecular Weight 375.43 g/mol: Famotidine Disalt with molecular weight 375.43 g/mol is used in clinical research trials, where precise dosing control is critical. Stability Temperature 25°C: Famotidine Disalt with stability temperature 25°C is used in long-term storage protocols, where it maintains chemical integrity over time. Solubility in Water >100 mg/mL: Famotidine Disalt with solubility in water >100 mg/mL is used in intravenous solution preparation, where rapid dissolution and ease of administration are required. Particle Size D90 <50 μm: Famotidine Disalt with particle size D90 <50 μm is used in oral tablet manufacturing, where it enables uniform blending and consistent tablet density. Melting Point 169-170°C: Famotidine Disalt with melting point 169-170°C is used in heat-processed pharmaceutical compounding, where it resists degradation during formulation. Assay ≥98.5%: Famotidine Disalt with assay ≥98.5% is used in API quality verification, where it provides reproducible pharmacological outcomes. pH (1% Solution) 7.5-8.5: Famotidine Disalt with pH (1% solution) 7.5-8.5 is used in injectable preparations, where it ensures biocompatibility and minimizes local irritation. USP Compliant Grade: Famotidine Disalt with USP compliant grade is used in regulated drug manufacturing, where it meets stringent pharmacopeial standards for safety and quality. Low Endotoxin Content <1 EU/mg: Famotidine Disalt with low endotoxin content <1 EU/mg is used in sterile drug products, where it reduces the risk of pyrogenic reactions. |
Competitive Famotidine Disalt prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Famotidine Disalt shows up across clinics, pharmacies, and research benches as an alternative form of a trusted ingredient. Plenty of folks recognize the role of famotidine itself in addressing stomach acid problems. Gastrointestinal specialists often reach for this approach when working with patients who struggle with gastric ulcers, reflux, and similar complaints. You find this compound in medical settings that value predictability and clarity of dosing, thanks to its specific sodium-based salt form. The disalt version builds its use on the back of careful chemistry, designed to provide improved solubility and stability compared to its more common hydrochloride cousin.
Acid suppression drugs stand as some of the most commonly dispensed remedies worldwide. They fit into routine care for conditions like gastroesophageal reflux disease and duodenal ulcers. Increasingly, hospitals prefer reliable, easily administered medications, particularly when treating patients who need rapid intervention or have trouble swallowing tablets. In this context, famotidine disalt has quietly taken on a distinct, if sometimes overlooked, role.
Salt forms of active pharmaceutical ingredients can make a huge difference in day-to-day clinical outcomes. Imagine a patient comes into the emergency room unable to swallow due to a severe esophageal stricture. In such moments, doctors can’t afford the luxury of guesswork around medication absorption. This is where famotidine disalt’s increased water solubility comes into play. Solutions prepared from this ingredient get absorbed more reliably and more quickly—a small but meaningful detail that has often tipped the scales toward better symptom relief.
Conventional famotidine, usually present as the hydrochloride salt, works well for the vast majority of pill-takers. But some situations call for a product that dissolves with even greater ease, leaving less sediment or residue after mixing. For researchers and compounding pharmacists, this subtle difference makes famotidine disalt a valuable tool. Those working in animal health or pediatric settings often prize it for exactly these reasons. Faster dissolution translates into more flexible dosing, especially important for patients who need precise titration or have unique intake requirements.
Years of hospital work taught me plenty about practical advantages and occasional limitations of different drug forms. In the late nights of on-call pharmacy rounds, requests sometimes landed for famotidine solutions that wouldn’t leave behind gritty, undissolved powder. Technicians could spend less time shaking bottles and more time ensuring patients got the relief they needed. With famotidine disalt, the reconstituted solutions stayed clear, even at higher concentrations, which definitely helped when managing enteral feeds or intravenous admixtures for sicker patients. Nobody pays much attention to that detail until a nasogastric tube clogs in the middle of a busy shift.
It’s easy, working behind a counter or compounding bench, to overlook how these small formulation quirks affect patient outcomes. Experienced pharmacists remember which products play nicely with common solvents and which ones refuse to blend in. These details go unmentioned in textbooks, but they shape patient care profoundly every week.
Most medical professionals recognize famotidine as an H2-receptor blocker, designed to lower stomach acid and ease discomfort from gastritis, ulcer disease, and reflux symptoms. The disalt formulation preserves this fundamental mechanism while offering distinct physical chemistry properties. Its appearance is typically a white or off-white powder, nearly odorless, ready for fast mixing in solutions. The improved solubility mentioned earlier means it handles higher-concentration formulations, supporting situations where space is tight, and every milliliter counts.
In research settings, scientists choose famotidine disalt not only for its physical characteristics but also for its compatibility with lab workflows. Animal scientists appreciate that flexible dosing makes it easier to tailor interventions, reducing waste and ensuring compliance with strict study protocols. They can count on precise measurement in every syringe, without fighting clumps or floating crystals. This reliability means studies seeking to advance clinical care don’t get derailed by formulation hiccups.
Choosing the right salt form often boils down to the end user’s needs. The hydrochloride form holds obvious advantages: it's been on the market longest, it's widely available, and generic versions keep costs reasonable. For most people on maintenance therapy, these attributes matter more than anything else. Yet, there are situations where more nuanced options serve better. Disalt gives doctors and pharmacists more flexibility in administration. Hospitals with high volumes of patients needing tailored treatment—especially those relying on custom blends or intravenous routes—find this compound brings less hassle and greater consistency.
Another notable difference comes into focus in situations where sodium content is a concern. Healthcare teams monitoring a patient's total salt intake might prefer to stick with hydrochloride. On the flip side, certain clinical pathways need the buffering effect of sodium salts, offering an edge during acute care. That subtle benefit often escapes attention outside of specialized settings, but for a narrow patient group, it sometimes tips the balance toward using the disalt.
Talk with patients who spend weeks or months in the hospital, and you’ll quickly hear frustration about clogged tubes, inconsistent drug effects, and flavor issues. Nurses juggling dozens of medication passes welcome products that dissolve fast and draw up easily into syringes. During my early days working on inpatient wards, I watched experienced nurses reach for famotidine disalt in those long, stressful shifts—especially where time meant the difference between comfort and distress.
For infants and children, particularly those fed through tubes, more predictable administration leads to better symptom control and fewer interruptions. Pediatric pharmacists have long advocated for solutions that grant accurate dosing without undissolved bits floating on top of a solution. Such details directly affect a parent’s sense of reassurance and their child’s comfort—a testament to the outsized impact of what seems like a minor formulation change.
In a landscape where counterfeit medicines remain a global risk, purity and quality assurance can’t be left to chance. Famotidine disalt produced under strict standards—meeting demands for identity, strength, and non-contamination—gives health systems confidence in their supply chain. Clinicians lean heavily on manufacturers who disclose batch testing and provide clear documentation, crucial for institutions that face regulatory scrutiny or serve immunocompromised populations.
Manufacturers producing famotidine disalt that meets these standards support trustworthy, effective clinical practice. Without this, the risk to patient safety grows, undermining hard-won advances in treatment. For professionals on the ground, practical accessibility means that when they need this product, it can be sourced reliably, with no surprises in performance.
Hospital formulary committees weigh dozens of factors when building a medication roster. Cost, reliability, and patient acceptance all matter. Famotidine disalt earns its place as a specialized option, not a one-size-fits-all remedy but a tailored choice where solubility and consistent delivery take priority. Some institutions have shifted toward favoring it in intensive care or pediatric wards, citing the cleaner preparation process and reduced rate of administration errors. These shifts tend to follow close consultation with front-line staff—doctors, nurses, and pharmacists who manage the daily grind of medication administration.
As the medical field evolves, more facilities invest in staff training to maximize the benefits of unique drug salts. This means moving beyond standard oral tablets and into liquid or injectable formats that better fit patient realities. With broader knowledge, health systems create smarter formularies and reduce the risk of unintentional side effects or failed treatments due to faulty administration.
In every hospital, patient feedback acts as a constant reminder that good medicine goes beyond chemical action. It involves taste, ease of use, and comfort. A feeding tube blocked by undissolved medicine isn’t just an inconvenience—it’s a real threat to nutrition, hydration, and treatment continuity. For elderly patients struggling with complex medication regimens, any simplification is a gift. Famotidine disalt brings this kind of practical advantage for patients most in need of fast symptom relief and reduced burden of care.
Doctors and nurses often note improved satisfaction when using medications that fit smoothly into established routines. Pharmacists interviewing patients at discharge hear fewer complaints about bitter aftertastes or inconsistent results. The less the medicine interferes with daily routines, the more likely patients are to stick with their prescribed regimens.
Medicine rarely stands still. As with any product, famotidine disalt’s success depends on ongoing collaboration between manufacturers, clinicians, and end users. Greater transparency around sourcing, improved batch tracking, and open communication about manufacturing standards strengthen trust up and down the supply chain. Comprehensive education for healthcare staff about the subtle but real differences between salt forms can head off administration errors, improve outcomes, and reassure patients.
In my own experience, hands-on demonstrations during pharmacy training sessions made a bigger difference than reading any package insert. Staff left more confident in their ability to prepare and administer the medication. Some institutions now offer regular in-service sessions on drug formulation differences, which cut down on confusion during new product rollouts.
Editorial content on pharmaceuticals stands or falls based on its trustworthiness, depth of experience, usefulness, and demonstrated accuracy. Medical professionals, pharmacists, and informed patients all understand that no product is perfect for every scenario. Experience, both in research and direct patient care, highlights where a new product shines or falls short. For famotidine disalt, the story revolves around its ability to fill specific clinical needs while maintaining the safety and reliability that medical teams demand.
No two patients are identical. A pharmacist balancing the needs of a premature infant on tube feeds or a trauma patient with limited IV access understands the stakes. Products that are easy to measure, quick to dissolve, and supported by strong quality control processes give everyone—from nurses to patients—greater peace of mind. Combined with clear communication and appropriate educational resources, these advantages compound over time, improving outcomes across entire care teams.
Looking ahead, the role of specialized drug formulations remains critical in patient care. As treatment protocols grow more sophisticated, medicines like famotidine disalt will likely see expanded use wherever patient comfort and administration efficiency come into play. With continued efforts to support transparency, reinforce quality control, and educate staff, the healthcare system can make the most of innovations that seem small at first glance but matter deeply in practice.
Hospitals and clinics face relentless pressure to do more with less. Anything that streamlines care, reduces errors, and cuts down on waste carries real-world benefits. In this context, the nuanced choice of salt form in medications becomes more than a technicality. It reflects a growing dedication to meeting individual patient needs in new and subtle ways.
Personal stories anchor the value of compounds like famotidine disalt. From a pharmacist’s careful compounding bench to a nurse’s midnight rounds, the need for reliability, speed, and flexibility in medication is a recurring theme. For families shepherding children through prolonged hospital stays or older adults fighting chronic gastric issues, every improvement in medication quality matters.
Product development in healthcare never reaches a final destination. Every new salt form, every enhanced protocol speaks to a broader pursuit of dignity, comfort, and better care. As patients and practitioners alike seek out options that fit their evolving realities, products like famotidine disalt comprise one small part of a much bigger story—one where patient needs, clinical science, and supply integrity all converge in care that respects both science and humanity.